Received Feb 13, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (JANSSEN)) | JANSSEN | UNK | 1805020 | — |
| COVID19 | COVID19 (COVID19 (JANSSEN)) | JANSSEN | UNK | — | — |
Blood clot; This spontaneous report received from a consumer concerned a male patient of unspecified age. The patient's height and weight were not reported. Age at time of vaccination was unknown. No past medical history, concurrent conditions or pre-existing medical conditions were reported. The patient received janssen covid-19 vaccine (suspension for injection, intramuscular, batch number not reported) dose, frequency and therapy dates not reported, additional dosage information included: Dose series 1, for covid-19 prophylaxis. The batch number was not reported and has been requested. No concomitant medications were reported. On an unspecified date, the patient experienced blood clot. (Dose series 1). Patient's spouse reported that way back during the days of Covid, the patient got the Johnson and Johnson vaccine and shortly, he got blood clot from it. The doctors said it was probably caused by the vaccine he took. The action taken with janssen covid-19 vaccine was not applicable. The outcome of blood clot was not reported. This report was serious (other medically important condition).; Sender's Comments: V0:Thrombosis. Insufficient information is available to make a causality assessment. Therefore, this event is considered unclassifiable.